Status:
COMPLETED
Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon
Lead Sponsor:
PharmEvo Pvt Ltd
Conditions:
Hepatitis C, Chronic
Eligibility:
All Genders
17-80 years
Phase:
PHASE4
Brief Summary
Title Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin with or without Interferon among Pakistani Population: A real life trial Hepatitis Eradication Accuracy Trial of Sofosbuvir (HEATS) Study ...
Detailed Description
Indication Chronic Hepatitis C Virus (HCV) infection (serum HCV RNA level, \>10,000 IU per milliliter) with or without cirrhosis Primary Objective o Proportion of participants with sustained virologic...
Eligibility Criteria
Inclusion
- Men and women, 18 years of age or older,
- Treatment -Naïve and not responded with the previous therapy
- Cirrhosis
- Not previously enrolled in any trial of Sofosbuvir
Exclusion
- Not given informed consent
- Pregnancy
Key Trial Info
Start Date :
June 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2018
Estimated Enrollment :
573 Patients enrolled
Trial Details
Trial ID
NCT02804386
Start Date
June 1 2016
End Date
January 30 2018
Last Update
September 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ojha, Duhs
Karachi, Sindh, Pakistan